Related Experiment Video
Updated: Apr 19, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Aortic Valve Function Under Support of a Left Ventricular Assist Device: Continuous vs. Dynamic Speed Support.
Selim Bozkurt1, Frans N van de Vosse, Marcel C M Rutten
1Department of Biomedical Engineering, Eindhoven University of Technology, Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands, s.bozkurt@tue.nl.
Continuous flow left ventricular assist devices (CF-LVADs) can strain the aortic valve. Optimizing pump flow timing, particularly at mid-diastole, may improve aortic valve function during CF-LVAD support.
Area of Science:
- Cardiovascular Engineering
- Biomedical Devices
- Hemodynamics
Background:
- Continuous flow left ventricular assist devices (CF-LVADs) provide constant hemodynamic support to failing hearts.
- CF-LVADs alter aortic valve loading conditions, potentially leading to aortic insufficiency with long-term use.
Purpose of the Study:
- To investigate the impact of varying speed continuous flow left ventricular assist device support on aortic valve function.
- To determine if optimizing pump flow timing can mitigate adverse effects on the aortic valve.
Main Methods:
- Utilized a mock circulatory system with a Medtronic freestyle valve and a Micromed DeBakey CF-LVAD.
- Tested CF-LVADs at constant speeds (7500-11,500 rpm) to establish baseline outputs.
- Simulated varying speed support by adjusting pump flow timing, applying peak flow during systole and mid-diastole.
Main Results:
- Aortic valve ejection duration was longest when peak pump flow was applied at mid-diastole.
- Mean aortic valve area over the cardiac cycle was maximized with mid-diastolic peak pump flow.
- Altering the phase of the pump flow signal influenced aortic valve closing behavior.
Conclusions:
- Varying the timing of pump flow in CF-LVADs can positively impact aortic valve function.
- Applying peak pump flow during mid-diastole appears beneficial for aortic valve area and ejection duration.
- Optimized flow phasing may reduce aortic valve complications without compromising overall device support.
More Related Videos
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
08:21Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
Published on: October 11, 2022
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis III: Medical Management
Aortic Regurgitation IV: Nursing Management
Mitral Regurgitation III: Medical Management